Hematopoietic JAK2V617F-mediated clonal hematopoiesis: AIM2 understand mechanisms of atherogenesis
- PMID: 34396370
- PMCID: PMC8360421
- DOI: 10.20517/jca.2021.06
Hematopoietic JAK2V617F-mediated clonal hematopoiesis: AIM2 understand mechanisms of atherogenesis
Conflict of interest statement
Conflicts of interest Both authors declared that there are no conflicts of interest.
Figures
Comment on
-
The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis.Nature. 2021 Apr;592(7853):296-301. doi: 10.1038/s41586-021-03341-5. Epub 2021 Mar 17. Nature. 2021. PMID: 33731931 Free PMC article.
References
-
- Cordua S, Kjaer L, Skov V, et al.Prevalence and phenotypes of JAK2 V617F and calreticulin mutations in a Danish general population. Blood 2019;134:469–79. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous